BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28767097)

  • 1. Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms.
    Kaur J; Young BE; Fadel PJ
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective afferent renal denervation mitigates renal and splanchnic sympathetic nerve overactivity and renal function in chronic kidney disease-induced hypertension.
    Veiga AC; Milanez MIO; Ferreira GR; Lopes NR; Santos CP; De Angelis K; Garcia ML; Oyama LM; Gomes GN; Nogueira FN; Carvalho PM; Campos RR; Bergamaschi CT; Nishi EE
    J Hypertens; 2020 Apr; 38(4):765-773. PubMed ID: 31764582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic overactivity in uremia.
    Ksiazek A; Załuska W
    J Ren Nutr; 2008 Jan; 18(1):118-21. PubMed ID: 18089457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment.
    Neumann J; Ligtenberg G; Klein II; Koomans HA; Blankestijn PJ
    Kidney Int; 2004 May; 65(5):1568-76. PubMed ID: 15086894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of endurance training in altering renal sympathetic nerve activity in CKD?
    Howden EJ; Lawley JS; Esler M; Levine BD
    Auton Neurosci; 2017 May; 204():74-80. PubMed ID: 27908698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cause and consequences of sympathetic hyperactivity in chronic kidney disease.
    Kotanko P
    Blood Purif; 2006; 24(1):95-9. PubMed ID: 16361848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the Renal Nerves to Hypertension in a Rabbit Model of Chronic Kidney Disease.
    Sata Y; Burke SL; Gueguen C; Lim K; Watson AMD; Jha JC; Eikelis N; Jackson KL; Lambert GW; Denton KM; Schlaich MP; Head GA
    Hypertension; 2020 Nov; 76(5):1470-1479. PubMed ID: 32895021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?
    Underwood CF; Hildreth CM; Wyse BF; Boyd R; Goodchild AK; Phillips JK
    Acta Physiol (Oxf); 2017 Jan; 219(1):305-323. PubMed ID: 27247097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total renal denervation reduces sympathoexcitation to different target organs in a model of chronic kidney disease.
    Veiga GL; Nishi EE; Estrela HF; Lincevicius GS; Gomes GN; Simões Sato AY; Campos RR; Bergamaschi CT
    Auton Neurosci; 2017 May; 204():81-87. PubMed ID: 27932204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal denervation enhances GABA-ergic input into the PVN leading to blood pressure lowering in chronic kidney disease.
    Nishihara M; Takesue K; Hirooka Y
    Auton Neurosci; 2017 May; 204():88-97. PubMed ID: 27729205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroacupuncture and moxibustion decrease renal sympathetic nerve activity and retard progression of renal disease in rats.
    Paterno JC; Bergamaschi CT; Campos RR; Higa EM; Soares MF; Schor N; Freire AO; Teixeira VP
    Kidney Blood Press Res; 2012; 35(5):355-64. PubMed ID: 22473039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of sympathetic nervous system in the progression of chronic kidney disease in the era of catheter based sympathetic renal denervation.
    Petras D; Koutroutsos K; Kordalis A; Tsioufis C; Stefanadis C
    Curr Clin Pharmacol; 2013 Aug; 8(3):197-205. PubMed ID: 23173962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension in Chronic Kidney Disease.
    Hamrahian SM; Falkner B
    Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease.
    Malpas SC
    Physiol Rev; 2010 Apr; 90(2):513-57. PubMed ID: 20393193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathoexcitation by brain oxidative stress mediates arterial pressure elevation in salt-induced chronic kidney disease.
    Fujita M; Ando K; Kawarazaki H; Kawarasaki C; Muraoka K; Ohtsu H; Shimizu H; Fujita T
    Hypertension; 2012 Jan; 59(1):105-12. PubMed ID: 22083162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic renal failure--taming the sympathetic nervous system! New approach to delaying progression].
    Rump LC; Oberhauser V
    MMW Fortschr Med; 1999 Nov; 141(46):39-41. PubMed ID: 10795144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
    Hering D; Esler MD; Schlaich MP
    EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of blood pressure in chronic renal failure: determinants of hypertension and dialysis-related hypotension.
    Ligtenberg G
    Neth J Med; 1999 Jul; 55(1):13-8. PubMed ID: 10431550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sympathetic nervous system in chronic kidney disease.
    Ewen S; Ukena C; Linz D; Schmieder RE; Böhm M; Mahfoud F
    Curr Hypertens Rep; 2013 Aug; 15(4):370-6. PubMed ID: 23737218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic overactivity--the Cinderella of cardiovascular risk factors in dialysis patients.
    Vonend O; Rump LC; Ritz E
    Semin Dial; 2008; 21(4):326-30. PubMed ID: 18627567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.